
50 episodes

The New England Biolabs Podcast: Lessons from Lab and Life New England Biolabs
-
- Science
-
-
4.8 • 10 Ratings
-
The New England Biolabs podcast series, Lessons from Lab and Life, is dedicated to sharing helpful life lessons from successful scientists. From an overview of cutting edge research to finding sources of inspiration, our podcast is for science enthusiasts that like to ponder “what it all means”. Listen as leading researchers draw lessons from where scientific concepts (and misconceptions) have come from, where they are now, and where they are headed in the not-too-distant future. If you’ve got 20 minutes, we’ve got a story that just might interest you. Hosted by Lydia Morrison.
-
Interview with Dr. Charlotte Houldcroft: Sequencing Double stranded DNA Viruses
Hear Charlotte Houldcroft, lecturer at the University of Cambridge – talk sequencing, from double-stranded DNA viruses to ancient DNA.
-
Episode 49: Interview with Mihir Kekre: Antimicrobial Resistance and Pathogen Surveillance
Hear Mihir Kekre, who spent 4 years at the Centre for Genomic Pathogen Surveillance at the Wellcome Sanger Institute, share his experience in antimicrobial resistance research and pathogen surveillance.
-
Interview with Orley 'Chip' Taylor: Understanding the Monarch Butterfly
Hear Chip Taylor, founder of the non-profit Monarch Watch, share his research findings and explain how we can help protect this endangered insect.
-
Interview with Jessie Stickgold-Sarah: Teaching science communication
Hear MIT Lecturer Jessie Stickgold-Sarah, who shares her perspective on the importance of good communication skills –– especially in science.
-
Interview with Susan Aitken: Building a CLIA lab during a pandemic
Hear Susan Aitken, Molecular Laboratory Asst. Manager of the HUCL lab, which provided testing for Harvard and MIT students and staff during the pandemic.
-
Interview with Anu Rebbapragada: Building a Diagnostics Company During a Pandemic
Hear Dr. Anu Rebbapragada of FH Health – a Health-Tech company that was created early in the COVID-19 pandemic to address public diagnostic testing needs.